Mark Hura, the Pres. of $ORCL, sold 15,000 shares of the company on 12-24-2025 for an estimated $2,953,314. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.0% of their shares of this class of stock. Following this trade, they now own 234,077 shares of this class of $ORCL stock.
$ORCL Insider Trading Activity
$ORCL insiders have traded $ORCL stock on the open market 20 times in the past 6 months. Of those trades, 1 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:
- MICHAEL D. SICILIA (President, Industries) has made 0 purchases and 3 sales selling 66,048 shares for an estimated $20,029,695.
- CLAYTON M. MAGOUYRK (Chief Executive Officer) has made 0 purchases and 3 sales selling 71,241 shares for an estimated $19,301,524.
- JEFFREY BERG has made 0 purchases and 4 sales selling 49,365 shares for an estimated $13,971,266.
- STUART LEVEY (EVP, Chief Legal Officer) sold 19,758 shares for an estimated $5,927,400
- MARIA SMITH (EVP, Chief Accounting Officer) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $5,133,019.
- WILLIAM G PARRETT sold 11,500 shares for an estimated $3,519,000
- MARK HURA (Pres., Global Field Operations) sold 15,000 shares for an estimated $2,953,314
- NAOMI O SELIGMAN has made 0 purchases and 3 sales selling 7,748 shares for an estimated $1,849,678.
- RONA ALISON FAIRHEAD purchased 480 shares for an estimated $112,257
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ORCL Hedge Fund Activity
We have seen 1,839 institutional investors add shares of $ORCL stock to their portfolio, and 1,739 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 11,518,787 shares (+123.9%) to their portfolio in Q3 2025, for an estimated $3,239,543,655
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 9,369,998 shares (+61.2%) to their portfolio in Q3 2025, for an estimated $2,635,218,237
- JENNISON ASSOCIATES LLC added 8,800,546 shares (+2062.4%) to their portfolio in Q3 2025, for an estimated $2,475,065,557
- FMR LLC added 7,047,855 shares (+28.3%) to their portfolio in Q3 2025, for an estimated $1,982,138,740
- NORGES BANK added 6,255,302 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $1,367,596,676
- VANGUARD GROUP INC added 4,681,626 shares (+2.8%) to their portfolio in Q3 2025, for an estimated $1,316,660,496
- BLACKROCK, INC. added 4,417,021 shares (+3.3%) to their portfolio in Q3 2025, for an estimated $1,242,242,986
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ORCL Revenue
$ORCL had revenues of $16.1B in Q2 2026. This is an increase of 14.22% from the same period in the prior year.
You can track ORCL financials on Quiver Quantitative's ORCL stock page.
$ORCL Congressional Stock Trading
Members of Congress have traded $ORCL stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/07.
- REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $200,000 on 09/23, 09/18, 09/17 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 09/15, 09/12.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 09/12.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ORCL Analyst Ratings
Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 20 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 12/11/2025
- Bernstein issued a "Outperform" rating on 12/11/2025
- Stifel issued a "Buy" rating on 12/11/2025
- Deutsche Bank issued a "Buy" rating on 11/26/2025
- Baird issued a "Outperform" rating on 11/18/2025
- Barclays issued a "Overweight" rating on 10/17/2025
- Piper Sandler issued a "Overweight" rating on 10/17/2025
To track analyst ratings and price targets for $ORCL, check out Quiver Quantitative's $ORCL forecast page.
$ORCL Price Targets
Multiple analysts have issued price targets for $ORCL recently. We have seen 30 analysts offer price targets for $ORCL in the last 6 months, with a median target of $322.5.
Here are some recent targets:
- Kash Rangan from Goldman Sachs set a target price of $220.0 on 12/12/2025
- Brad Sills from B of A Securities set a target price of $300.0 on 12/11/2025
- John Difucci from Guggenheim set a target price of $400.0 on 12/11/2025
- Thomas Blakey from Cantor Fitzgerald set a target price of $320.0 on 12/11/2025
- Jackson Ader from Keybanc set a target price of $300.0 on 12/11/2025
- Derrick Wood from TD Cowen set a target price of $350.0 on 12/11/2025
- Tyler Radke from Citigroup set a target price of $370.0 on 12/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
